Drug Shortage Report for AURO-CEPHALEXIN
Report ID | 219262 |
Drug Identification Number | 02497743 |
Brand name | AURO-CEPHALEXIN |
Common or Proper name | AURO-CEPHALEXIN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CEPHALEXIN |
Strength(s) | 125MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 100 ml |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-12 |
Estimated end date | 2024-05-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-03-27 | French | Compare |
v4 | 2024-03-27 | English | Compare |
v3 | 2024-02-13 | English | Compare |
v2 | 2024-02-12 | French | Compare |
v1 | 2024-02-12 | English | Compare |
Showing 1 to 5 of 5